<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Zinc transporter 8 (ZnT8) is an islet beta-cell secretory granule membrane protein recently identified as an autoantibody antigen in type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to determine the prevalence and role of antibodies to ZnT8 (ZnT8As) in <z:hpo ids='HP_0003581'>adult-onset</z:hpo> <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: ZnT8As were measured by a radioimmunoprecipitation assay using recombinant ZnT8 COOH-terminal or NH(2)-terminal proteins in 193 patients with <z:hpo ids='HP_0003581'>adult-onset</z:hpo> autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> having antibodies to either GAD (GADAs) or IA-2 (IA-2As) and in 1,056 antibody-negative patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> from the Non Insulin Requiring Autoimmune <z:mp ids='MP_0002055'>Diabetes</z:mp> (NIRAD) study </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: ZnT8As-COOH were detected in 18.6% patients with autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> and 1.4% with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>ZnT8As-NH(2) were rare </plain></SENT>
<SENT sid="5" pm="."><plain>ZnT8As were associated with younger age and a high GADA titer </plain></SENT>
<SENT sid="6" pm="."><plain>The use of GADAs, IA-2As, and ZnT8As in combination allowed a stratification of clinical phenotype, with younger <z:hpo ids='HP_0011007'>age of onset</z:hpo> of <z:mp ids='MP_0002055'>diabetes</z:mp> and characteristics of more severe insulin deficiency (higher fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> and A1C, lower BMI, total cholesterol, and <z:chebi fb="4" ids="17855">triglycerides</z:chebi>) in patients with <z:hpo ids='HP_0000001'>all</z:hpo> three markers, with progressive attenuation in patients with two, one, and no antibodies (<z:hpo ids='HP_0000001'>all</z:hpo> P(trend) &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Autoantibody titers, association with high-risk HLA genotypes, and prevalence of thyroid peroxidase antibodies followed the same trend (<z:hpo ids='HP_0000001'>all</z:hpo> P &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: ZnT8As are detectable in a proportion of patients with <z:hpo ids='HP_0003581'>adult-onset</z:hpo> autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> and seem to be a valuable marker to differentiate clinical phenotypes </plain></SENT>
</text></document>